Brand name: Emtriva TM
Active ingredients: emtricitabine
What it is used for
Emtriva is indicated for the treatment of HIV in combination with other antiretroviral agents in adults and paediatric patients 12 years of age and older, weighing more than 33 kg. Evidence to support this claim is based on surrogate markers (plasma HIV RNA and CD4 count) in antiretroviral naive individuals and in antiretroviral experienced individuals with virological suppression (See Clinical Trials).
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Hard Gelatin Capsule with "200 mg" printed on a blue cap and "GILEAD" and corporate logo printed on a white body
Food interactions
For the active ingredient emtricitabine
- Take without regard to meals.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient emtricitabine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
